Abstract
Activation of the complement cascade occurs in most cases of acute poststreptococcal glomerulonephritis (APSGN) and results in the formation of the terminal complement complexes (TCC). To examine the possible role of TCC in the pathogenesis of glomerular injury in APSGN, we studied 30 patients with the clinical diagnosis of APSGN. All patients had an elevated plasma SC5b-9 concentration at the onset of clinical nephritis. Serial plasma concentrations showed an inverse linear relationship with time after onset of clinical disease (r=−0.59,P=0.0008), while plasma C3 concentrations showed a positive linear relationship (r=0.78,P=0.0001). Renal biopsies of 5 patients demonstrated co-localization of C5b-9, S-protein, and C3 deposition in a glomerular capillary loop and mesangial distribution. Urinary excretion of TCC in the acute phase of APSGN was not elevated and was not a useful marker of disease activity. These data suggest that in APSGN with terminal complement pathway activation the local generation of TCC may contribute to the pathogenesis of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Roy S III, Stapleton FB (1990) Changing perspectives in children hospitalized with poststreptococcal acute glomerulonephritis. Pediatr Nephrol 4:585–588
Wyatt RJ, Forristal J, West CD, Sugimoto S, Curd JG (1988) Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr Nephrol 2:219–223
Lovett DH, Hansch GM, Goppelt M, Resch K, Gemsa D (1987) Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 138:2473–2480
Rother K, Hansch GM, Ranterberg EW (1991) Complement in inflammation: induction of nephritides and progress to chronicity. Int Arch Allergy Appl Immunol 94:23–27
Abboud HE (1992) Growth factors and the mesangium. J Am Soc Nephrol 2:S185-S189
Matsell DG, Roy S III, Tamerius JD, Morrow PR, Kolb WP, Wyatt RJ (1991) Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. Am J Kidney Dis 12: 311–316
West CD, Northway JD, Davis NC (1964) Serum levels of beta-1c-globulin, a complement component, in the nephritides, lipoid nephrosis, and other conditions. J Clin Invest 43:1507–1517
Kohler PJ, Bensel R ten (1969) Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. Clin Exp Immunol 4:191–202
Cameron JS, Vick RM, Ogg CS, Seymour WM, Chautter C, Turner DR (1973) Plasma C3 and C4 concentrations in management of glomerulonephritis. BMJ 13:668–672
Mollnes TE, Ng VC, Peters DK, Lea T, Tschopp J, Harboe M (1986) Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. Clin Exp Immunol 65:73–79
Parra G, Platt JL, Falk RJ, Rodriguez-Iturbe B, Michael AF (1984) Cell populations and membrane attack complex in glomeruli of patients with post streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. Clin Exp Immunol 33:329–332
Hulton SA, Risdon RA, Dillon MJ (1992) Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor, and persistently low complement C3 and C5. Pediatr Nephrol 6:239–243
Rus HG, Niculescu F, Nanulescu M, Anca Cristea, Florescu P (1986) Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases. Clin Exp Immunol 65:66–72
Bariety J, Hinglais N, Bhakdi S, Maudet C, Rouchon M, Kazatchkine D (1989) Immunohistochemical study of complement S-protein (vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. Clin Exp Immunol 75:76–81
Morgan BP (1989) Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 264: 1–14
Kolb WP, Muller-Eberhard HJ (1975) The membrane attack mechanism of complement. J Exp Med 141:724–735
Muller-Eberhard HJ (1986) The membrane attack complex of complement. Annu Rev Immunol 4:503–528
Bhakdi S, Kaflein R, Halstensen TS, Hugo F, Preissner KT, Mollnes TE (1988) Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Clin Exp Immunol 74:459–464
Biesecker G (1990) The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor. J Immunol 145: 209–214
Hansch GM, Schieren G, Wagner C, Schonermark M (1992) Immune damage to the mesangium: antibody and complement mediated stimulation and destruction of mesangial cells. J Am Soc Nephrol 2:S139-S143
Coleman DL, Ruef C (1992) Interleukin-6: an autocrine regulator of mesangial cell growth. Kidney Int 41:604–606
Abboud HE (1992) Platelet derived growth factor and mesangial cells. Kidney Int 41:581–583
Salant DJ, Belok S, Madaio MP, Couser WG (1980) A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66:1339–1350
Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG (1989) Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35: 60–68
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsell, D.G., Wyatt, R.J. & Gaber, L.W. Terminal complement complexes in acute poststreptococcal glomerulonephritis. Pediatr Nephrol 8, 671–676 (1994). https://doi.org/10.1007/BF00869086
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00869086